Share This

Public company info - Shanghai Fosun Pharmaceutical (Group) Co. Ltd. - H Shares , 02196.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Shanghai Fosun Pharmaceutical (Group) Co. Ltd. - H Shares, 02196.HK - Cash Flow 2022-12 2021-12 2020-12 2019-12 2018-12 2017-12 2016-12 2015-12 2014-12 2013-12 2012-12 2011-12 2010-12 2009-12
Net Cash Flow from Operating Activities 4,907,470 4,790,806 3,561,412 4,009,141 3,700,141 3,159,917 2,589,515 1,954,891 1,599,694 1,346,822 893,591 533,633 291,611 336,543
Net Cash Flow from Return on Investments & Servicing of Finance -1,798,718 -1,543,642 -1,597,524 -1,524,826 -1,440,466 -1,081,952 -875,319 -888,569 -900,762 -777,236 -410,029 -326,419 -165,924 71,684
　Interest Received 0 0 0 0 0 0 0 0 0 0 0 4,577 0 0
　Interest Paid -937,336 -810,802 -810,164 -1,007,722 -801,800 -562,131 -454,984 -454,865 -339,581 -333,966 -310,480 -246,872 -170,448 -144,794
　Dividend Received 717,499 662,251 572,902 568,121 540,083 526,873 422,201 357,762 225,361 280,783 297,446 212,295 212,855 374,198
　Dividend Paid -1,578,881 -1,395,091 -1,360,262 -1,085,225 -1,178,749 -1,046,694 -842,536 -791,466 -786,542 -724,053 -396,995 -296,419 -208,331 -157,720
　Others 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Taxes (Paid) / Refunded -689,899 -852,991 -981,638 -786,728 -750,036 -579,691 -479,476 -333,863 -460,741 -335,189 -228,074 -216,983 -88,248 -74,674
Net Cash Flow from Investing Activities -4,781,537 -4,519,740 -5,279,131 -740,083 -5,784,998 -11,030,975 -2,869,296 -2,227,672 -2,642,437 -2,084,235 -1,272,526 -1,923,047 -475,249 -745,241
　Additions to Fixed Assets -5,888,839 -4,972,799 -4,437,119 -3,962,059 -3,174,911 -2,170,617 -1,921,962 -1,235,536 -1,119,437 -1,040,055 -1,160,597 -796,833 -339,167 -348,068
　Disposal of Fixed Assets 107,130 97,098 8,881 33,980 29,179 100,176 61,807 21,999 126,972 5,972 9,437 3,833 1,845 1,514
　Increase in Investments -2,698,044 -2,731,433 -1,224,040 -1,340,581 -2,773,978 -10,345,216 -1,645,130 -3,104,312 -3,137,722 -2,617,814 -733,396 -1,341,887 -1,188,333 -746,026
　Decrease in Investments 4,540,257 3,194,236 1,477,871 4,351,934 723,573 1,026,300 1,069,922 2,123,506 1,256,471 1,258,571 1,189,652 313,263 1,137,299 381,339
　Net Cash Flow with Related Parties -1,109,218 14,792 1,512,429 2,745,050 586,443 980,351 40,607 -189,081 -1,383,846 -179,759 29,665 16,031 530 -7,839
　Others 267,177 -121,634 -2,617,153 -2,568,407 -1,175,304 -621,969 -474,540 155,752 1,615,125 488,850 -607,287 -117,454 -87,423 -26,161
Net Cash Flow before Financing Activities -2,362,684 -2,125,567 -4,296,881 957,504 -4,275,359 -9,532,701 -1,634,576 -1,495,213 -2,404,246 -1,849,838 -1,017,038 -1,932,816 -437,810 -411,688
Net Cash Flow from Financing Activities 6,944,692 1,386,485 3,637,555 156,968 5,118,084 11,517,452 2,743,549 1,797,046 2,989,193 125,912 2,772,382 1,395,923 2,199,327 676,732
　New Loans 30,027,529 29,202,760 17,972,653 11,548,539 12,535,348 18,214,886 10,605,833 9,321,698 5,894,058 2,815,566 1,364,993 4,006,942 2,817,114 1,756,456
　Loans Repayment -26,470,943 -27,558,827 -15,729,859 -13,968,699 -10,228,281 -9,318,046 -10,178,141 -7,361,501 -2,928,698 -2,494,086 -3,864,420 -4,203,050 -2,081,709 -1,071,885
　Fixed Income/Debt Instruments 0 0 0 0 0 0 0 0 0 0 1,985,875 1,576,000 985,500 0
　Repayment of Fixed Income/Debt Instruments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
　Equity Financing 4,509,453 0 0 0 2,224,574 1,640,536 2,275,850 28,405 1,407,679 0 3,098,769 0 635,392 0
　Net Cash Flow with Related Parties -1,109,218 14,792 1,512,429 2,745,050 586,443 980,351 40,607 -189,081 -1,383,846 -179,759 29,665 16,031 530 -7,839
　Others -12,129 -272,240 -117,668 -167,922 0 -275 -600 -2,475 0 -15,809 157,500 0 -157,500 0
Increase(Decrease) in Cash & Cash Equivalents 4,582,008 -739,082 -659,326 1,114,472 842,725 1,984,751 1,108,973 301,833 584,947 -1,723,926 1,755,344 -536,893 1,761,517 265,044
Cash & Cash Equivalents at Beginning of Year 6,459,717 7,333,511 8,284,371 7,175,005 6,350,319 4,538,037 3,348,594 3,010,155 2,416,261 4,171,574 2,428,219 2,971,131 1,213,385 949,056
Net Cash Flow due to Change in Exchange Rate/Others 128,342 -134,712 -300,164 -5,106 -18,039 -172,469 80,470 36,606 8,947 -31,387 -11,989 -6,019 -3,771 -715
Cash & Cash Equivalents at End of Year 11,170,067 6,459,717 7,324,881 8,284,371 7,175,005 6,350,319 4,538,037 3,348,594 3,010,155 2,416,261 4,171,574 2,428,219 2,971,131 1,213,385
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit Thousand Thousand Thousand
Auditor's Opinion 1 1 1 1 1 1 1 1 1 1 1 0 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.